These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94. Fuchs J; Rydzynski J; Hecker H; Mildenberger H; Bürger D; Harms D; V Schweinitz D; Eur J Pediatr Surg; 2002 Aug; 12(4):255-61. PubMed ID: 12369004 [TBL] [Abstract][Full Text] [Related]
35. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H; J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150 [TBL] [Abstract][Full Text] [Related]
36. First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases. Kollmannsberger C; Nichols C; Bamberg M; Hartmann JT; Schleucher N; Beyer J; Schöfski P; Derigs G; Rüther U; Böhlke I; Schmoll HJ; Kanz L; Bokemeyer C Ann Oncol; 2000 May; 11(5):553-9. PubMed ID: 10907948 [TBL] [Abstract][Full Text] [Related]
37. Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt. Czauderna P Front Biosci (Elite Ed); 2012 Jan; 4(1):470-9. PubMed ID: 22201887 [TBL] [Abstract][Full Text] [Related]
38. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 107 consecutive patients with limited- and extensive-stage non-small-cell lung cancer. Fetscher S; Brugger W; Engelhardt R; Kanz L; Hasse J; Frommhold H; Wenger M; Lange W; Mertelsmann R Ann Oncol; 1997 Jan; 8(1):57-64. PubMed ID: 9093708 [TBL] [Abstract][Full Text] [Related]
39. Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases. Davies JQ; de la Hall PM; Kaschula RO; Sinclair-Smith CC; Hartley P; Rode H; Millar AJ J Pediatr Surg; 2004 Sep; 39(9):1321-7. PubMed ID: 15359384 [TBL] [Abstract][Full Text] [Related]
40. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program. Elias AD; Ibrahim J; Richardson P; Avigan D; Joyce R; Reich E; McCauley M; Wheeler C; Frei E Biol Blood Marrow Transplant; 2002; 8(4):198-205. PubMed ID: 12017145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]